Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers, a Phase 0/I Study.

NCT07009184 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07009184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07009184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers, a Phase 0/I Study.
Lead sponsor
Radboud University Medical Center
Phase
Phase 1
Overall status
Recruiting
Start date
April 2, 2026
Completion date
December 31, 2026
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive solid tumor